首页 > 最新文献

Bioanalysis最新文献

英文 中文
WRIB Poster Awards winners 2023. 2023 年 WRIB 海报奖获奖者。
IF 1.8 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-02-01 Epub Date: 2024-01-25 DOI: 10.4155/bio-2024-0012
Jennifer Getz, Shannon McGrath, Gus Hui
{"title":"WRIB Poster Awards winners 2023.","authors":"Jennifer Getz, Shannon McGrath, Gus Hui","doi":"10.4155/bio-2024-0012","DOIUrl":"10.4155/bio-2024-0012","url":null,"abstract":"","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"185-189"},"PeriodicalIF":1.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139544846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LC-MS bioanalysis of protein biomarkers and protein therapeutics in formalin-fixed paraffin-embedded tissue specimens. 对福尔马林固定石蜡包埋组织标本中的蛋白质生物标记物和蛋白质疗法进行液相色谱-质谱生物分析。
IF 1.8 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-02-01 Epub Date: 2024-01-16 DOI: 10.4155/bio-2023-0210
Mashanipalya G Jagadeeshaprasad, Jianing Zeng, Naiyu Zheng

Formalin-fixed paraffin-embedded (FFPE) is a form of preservation and preparation for biopsy specimens. FFPE tissue specimens are readily available as part of oncology studies because they are often collected for disease diagnosis or confirmation. FFPE tissue specimens could be extremely useful for retrospective studies on protein biomarkers because the samples preserved in FFPE blocks could be stable for decades. However, LC-MS bioanalysis of FFPE tissues poses significant challenges. In this Perspective, we review the benefits and recent developments in LC-MS approach for targeted protein biomarker and protein therapeutic analysis using FFPE tissues and their clinical and translational applications. We believe that LC-MS bioanalysis of protein biomarkers in FFPE tissue specimens represents a great potential for its clinical applications.

福尔马林固定石蜡包埋(FFPE)是活检标本的一种保存和制备方式。FFPE 组织标本在肿瘤学研究中很容易获得,因为它们通常是为疾病诊断或确诊而收集的。FFPE 组织标本对于蛋白质生物标记物的回顾性研究非常有用,因为保存在 FFPE 块中的样本可以稳定数十年。然而,对 FFPE 组织进行 LC-MS 生物分析是一项重大挑战。在本视角中,我们回顾了利用 FFPE 组织进行靶向蛋白质生物标记物和蛋白质治疗分析的 LC-MS 方法的优势和最新进展,以及它们在临床和转化方面的应用。我们相信,LC-MS 生物分析 FFPE 组织标本中的蛋白质生物标记物具有巨大的临床应用潜力。
{"title":"LC-MS bioanalysis of protein biomarkers and protein therapeutics in formalin-fixed paraffin-embedded tissue specimens.","authors":"Mashanipalya G Jagadeeshaprasad, Jianing Zeng, Naiyu Zheng","doi":"10.4155/bio-2023-0210","DOIUrl":"10.4155/bio-2023-0210","url":null,"abstract":"<p><p>Formalin-fixed paraffin-embedded (FFPE) is a form of preservation and preparation for biopsy specimens. FFPE tissue specimens are readily available as part of oncology studies because they are often collected for disease diagnosis or confirmation. FFPE tissue specimens could be extremely useful for retrospective studies on protein biomarkers because the samples preserved in FFPE blocks could be stable for decades. However, LC-MS bioanalysis of FFPE tissues poses significant challenges. In this Perspective, we review the benefits and recent developments in LC-MS approach for targeted protein biomarker and protein therapeutic analysis using FFPE tissues and their clinical and translational applications. We believe that LC-MS bioanalysis of protein biomarkers in FFPE tissue specimens represents a great potential for its clinical applications.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"245-258"},"PeriodicalIF":1.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139471805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular bioanalysis of moxifloxacin and ketorolac tromethamine in rabbit lacrimal matrix using liquid chromatography-tandem mass spectrometry. 利用液相色谱-串联质谱法对兔泪液基质中的莫西沙星和酮咯酸氨丁三醇进行眼部生物分析。
IF 1.8 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-02-01 Epub Date: 2024-01-10 DOI: 10.4155/bio-2023-0233
Amol Chhatrapati Bisen, Rabi Sankar Bhatta

Aim: The fixed-dose combination of moxifloxacin (MOXI) and ketorolac tromethamine (KTR) is widely used for the treatment of bacterial keratitis. Thus, a new LC-MS/MS method was developed to determine MOXI and KTR in lacrimal fluid. Methods: Bioanalysis was performed using a Shimadzu 8050 LC-MS/MS in electrospray ionization-positive mode and the method was validated per US FDA guidelines. Isocratic separation was performed with a Waters Symmetry C18 column using methanol and 0.1% formic acid containing deionized water (85:15, v/v). Results & conclusion: An easy, quick and selective method was established and applied to assess the ocular pharmacokinetic profile of a commercially available formulation containing MOXI and KTR. Based on the pharmacokinetic data, this work describes pharmacokinetics-based dosage regimen calculations and their clinical significance.

目的:莫西沙星(MOXI)和酮咯酸氨丁三醇(KTR)的固定剂量复方制剂被广泛用于治疗细菌性角膜炎。因此,我们开发了一种新的 LC-MS/MS 方法来测定泪液中的 MOXI 和 KTR。方法:使用岛津 8050 LC-MS/MS,在电喷雾离子化正离子模式下进行生物分析,并根据美国 FDA 指南对该方法进行了验证。采用 Waters Symmetry C18 色谱柱,以甲醇和含去离子水的 0.1% 甲酸(85:15, v/v)进行等度分离。结果与结论:本研究建立了一种简便、快速、选择性强的方法,用于评估含有 MOXI 和 KTR 的市售制剂的眼药代动力学特征。根据药代动力学数据,本研究阐述了基于药代动力学的剂量方案计算及其临床意义。
{"title":"Ocular bioanalysis of moxifloxacin and ketorolac tromethamine in rabbit lacrimal matrix using liquid chromatography-tandem mass spectrometry.","authors":"Amol Chhatrapati Bisen, Rabi Sankar Bhatta","doi":"10.4155/bio-2023-0233","DOIUrl":"10.4155/bio-2023-0233","url":null,"abstract":"<p><p><b>Aim:</b> The fixed-dose combination of moxifloxacin (MOXI) and ketorolac tromethamine (KTR) is widely used for the treatment of bacterial keratitis. Thus, a new LC-MS/MS method was developed to determine MOXI and KTR in lacrimal fluid. <b>Methods:</b> Bioanalysis was performed using a Shimadzu 8050 LC-MS/MS in electrospray ionization-positive mode and the method was validated per US FDA guidelines. Isocratic separation was performed with a Waters Symmetry C<sub>18</sub> column using methanol and 0.1% formic acid containing deionized water (85:15, v/v). <b>Results & conclusion:</b> An easy, quick and selective method was established and applied to assess the ocular pharmacokinetic profile of a commercially available formulation containing MOXI and KTR. Based on the pharmacokinetic data, this work describes pharmacokinetics-based dosage regimen calculations and their clinical significance.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"219-232"},"PeriodicalIF":1.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139401633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Free hemoglobin determination at patients' bedside to evaluate hemolysis. 床边检测游离血红蛋白评价溶血情况。
IF 1.8 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-01-01 Epub Date: 2023-12-05 DOI: 10.4155/bio-2023-0116
Bastien Baud, Anne Marie Dupuy, Samuel Zozor, Stéphanie Badiou, Anne Sophie Bargnoux, Olivier Mathieu, Jean Paul Cristol

Background: The authors report the relevance of using a point of care test (Helge®) for free hemoglobin determination and concordance of the values the with Cobas® 8000 and spectrophotometer methods. Results: The within-run of the point of care test was <3%. Good correlations among the three methods were observed and an acceptable concordance for hemolysis index values from 50 mg/dl. An excellent agreement between the Cobas 8000 and the spectrophotometer was found. Conclusion: Automated methods represent methods of choice for free hemoglobin determination. An advantage of the Helge system is that it can be applied to samples experiencing a delay in evaluation due to the long distance between the collection site and the central laboratory. Another advantage is its use at the bedside, in the monitoring of extracorporeal membrane oxygenation patients.

背景:作者报告了使用护理点试验(Helge®)测定游离血红蛋白的相关性,以及与Cobas®8000和分光光度计方法的一致性。结论:自动化方法是游离血红蛋白测定的首选方法。Helge系统的一个优点是,它可以应用于由于采集地点和中心实验室之间的距离较远而导致评估延迟的样品。另一个优点是它可以在床边使用,用于监测体外膜氧合患者。
{"title":"Free hemoglobin determination at patients' bedside to evaluate hemolysis.","authors":"Bastien Baud, Anne Marie Dupuy, Samuel Zozor, Stéphanie Badiou, Anne Sophie Bargnoux, Olivier Mathieu, Jean Paul Cristol","doi":"10.4155/bio-2023-0116","DOIUrl":"10.4155/bio-2023-0116","url":null,"abstract":"<p><p><b>Background:</b> The authors report the relevance of using a point of care test (Helge<sup>®</sup>) for free hemoglobin determination and concordance of the values the with Cobas<sup>®</sup> 8000 and spectrophotometer methods. <b>Results:</b> The within-run of the point of care test was <3%. Good correlations among the three methods were observed and an acceptable concordance for hemolysis index values from 50 mg/dl. An excellent agreement between the Cobas 8000 and the spectrophotometer was found. <b>Conclusion:</b> Automated methods represent methods of choice for free hemoglobin determination. An advantage of the Helge system is that it can be applied to samples experiencing a delay in evaluation due to the long distance between the collection site and the central laboratory. Another advantage is its use at the bedside, in the monitoring of extracorporeal membrane oxygenation patients.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"65-74"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138481789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges and current advances in the methodology of thyroglobulin measurements. 甲状腺球蛋白测量方法的挑战和当前进展。
IF 1.8 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-01-01 Epub Date: 2023-11-22 DOI: 10.4155/bio-2023-0149
Ilona Đorić, Sonja Šelemetjev

Thyroglobulin (Tg) is a large protein secreted exclusively by the thyroid gland. In a clinical setting, it is measured for the purpose of follow-up of thyroidectomy patients. However, Tg measurements are often impeded by the presence of Tg autoantibodies and/or heterophylic antibodies that interfere with most measuring platforms. This presents a global problem in thyroid cancer patients who need to be postoperatively monitored for recurrent or residual disease. Therefore, in this paper we offer an overview of the existing methodologies and alternative approaches for Tg measurements that are a focus of research worldwide. These include Tg mRNA measurements, exosomal Tg detection, the use of alternative analytes (liquid biopsies) and the development of new approaches for preanalytical sample treatment.

甲状腺球蛋白(Tg)是一种由甲状腺分泌的大蛋白。在临床环境中,它被测量为甲状腺切除术患者的随访目的。然而,Tg测量经常受到Tg自身抗体和/或干扰大多数测量平台的异源抗体的存在的阻碍。这提出了一个全球性的问题,甲状腺癌患者谁需要术后监测复发或残留的疾病。因此,在本文中,我们提供了现有的方法和替代方法的Tg测量的概述,这是全球研究的焦点。这些包括Tg mRNA测量,外泌体Tg检测,替代分析物(液体活检)的使用以及分析前样品处理新方法的开发。
{"title":"Challenges and current advances in the methodology of thyroglobulin measurements.","authors":"Ilona Đorić, Sonja Šelemetjev","doi":"10.4155/bio-2023-0149","DOIUrl":"10.4155/bio-2023-0149","url":null,"abstract":"<p><p>Thyroglobulin (Tg) is a large protein secreted exclusively by the thyroid gland. In a clinical setting, it is measured for the purpose of follow-up of thyroidectomy patients. However, Tg measurements are often impeded by the presence of Tg autoantibodies and/or heterophylic antibodies that interfere with most measuring platforms. This presents a global problem in thyroid cancer patients who need to be postoperatively monitored for recurrent or residual disease. Therefore, in this paper we offer an overview of the existing methodologies and alternative approaches for Tg measurements that are a focus of research worldwide. These include Tg mRNA measurements, exosomal Tg detection, the use of alternative analytes (liquid biopsies) and the development of new approaches for preanalytical sample treatment.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"49-60"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138290194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA. 比较支链 DNA 和逆转录酶定量聚合酶链反应方法对脂质纳米颗粒封装的 mRNA 进行定量。
IF 1.9 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-01-01 Epub Date: 2024-10-18 DOI: 10.1080/17576180.2024.2411914
Syed Ali, Matt Bruno, Caleb Celestin, Pratibha Chauhan, Marissa Mitola, Shilpa Sharma, Chiaowen Joyce Hsiao, Mengying Li, Lei Ci, Douglas Burdette, Harkewal Singh

Messenger RNA (mRNA)-based therapeutics have emerged as a promising modality for various clinical applications, necessitating robust methods for mRNA quantification. This biodistribution study compares the performance of branched DNA and reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) assays for measuring lipid nanoparticle-encapsulated mRNA. Following intravenous administration of nascent peptide imaging luciferase mRNA (1 mg/kg) to rats, mRNA levels in various tissues and serum were quantified using both assays. Statistical analyses, including Bland-Altman, Deming regression and Passing-Bablok regression, were employed to assess method comparability and reproducibility. The results indicated that mRNA pharmacokinetics measured by branched DNA and RT-qPCR were largely consistent across tissues, with RT-qPCR showing greater reproducibility across multiple laboratories. RT-qPCR also demonstrated a wider dynamic range and higher sensitivity, making it a more versatile option for large-scale studies. Despite some differences in data due to tissue types and timepoints, both methods provided comparable pharmacokinetic profiles for mRNA quantification. This study underscores the importance of selecting an appropriate quantification method based on study requirements and highlights RT-qPCR's adaptability for multisite research, especially for the clinical development of mRNA-based therapeutics.

以信使 RNA (mRNA) 为基础的疗法已成为各种临床应用的一种很有前途的方式,这就需要有可靠的 mRNA 定量方法。这项生物分布研究比较了支链 DNA 和逆转录酶定量聚合酶链反应(RT-qPCR)测定法在测量脂质纳米颗粒封装的 mRNA 方面的性能。给大鼠静脉注射新生肽成像荧光素酶 mRNA(1 毫克/千克)后,使用这两种测定法对各种组织和血清中的 mRNA 水平进行量化。统计分析包括布兰德-阿尔特曼、戴明回归和帕森-巴勃洛克回归,以评估方法的可比性和重现性。结果表明,通过支链 DNA 和 RT-qPCR 测定的 mRNA 药代动力学在不同组织中基本一致,而 RT-qPCR 在多个实验室中显示出更高的重现性。RT-qPCR 还显示出更宽的动态范围和更高的灵敏度,使其成为大规模研究的更多功能选择。尽管由于组织类型和时间点的不同,数据存在一些差异,但两种方法都能提供可比的 mRNA 定量药代动力学曲线。这项研究强调了根据研究要求选择合适的定量方法的重要性,并突出了 RT-qPCR 对多点研究的适应性,尤其是对基于 mRNA 的疗法的临床开发。
{"title":"A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA.","authors":"Syed Ali, Matt Bruno, Caleb Celestin, Pratibha Chauhan, Marissa Mitola, Shilpa Sharma, Chiaowen Joyce Hsiao, Mengying Li, Lei Ci, Douglas Burdette, Harkewal Singh","doi":"10.1080/17576180.2024.2411914","DOIUrl":"10.1080/17576180.2024.2411914","url":null,"abstract":"<p><p>Messenger RNA (mRNA)-based therapeutics have emerged as a promising modality for various clinical applications, necessitating robust methods for mRNA quantification. This biodistribution study compares the performance of branched DNA and reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) assays for measuring lipid nanoparticle-encapsulated mRNA. Following intravenous administration of nascent peptide imaging luciferase mRNA (1 mg/kg) to rats, mRNA levels in various tissues and serum were quantified using both assays. Statistical analyses, including Bland-Altman, Deming regression and Passing-Bablok regression, were employed to assess method comparability and reproducibility. The results indicated that mRNA pharmacokinetics measured by branched DNA and RT-qPCR were largely consistent across tissues, with RT-qPCR showing greater reproducibility across multiple laboratories. RT-qPCR also demonstrated a wider dynamic range and higher sensitivity, making it a more versatile option for large-scale studies. Despite some differences in data due to tissue types and timepoints, both methods provided comparable pharmacokinetic profiles for mRNA quantification. This study underscores the importance of selecting an appropriate quantification method based on study requirements and highlights RT-qPCR's adaptability for multisite research, especially for the clinical development of mRNA-based therapeutics.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"1141-1154"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11583626/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142457040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determination of drugs of abuse and metabolites in plasma microsamples by LC-MS/MS after microQuEChERS extraction. 微量 QuEChERS 萃取后通过 LC-MS/MS 测定血浆微量样本中的滥用药物和代谢物。
IF 1.9 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-01-01 Epub Date: 2024-09-27 DOI: 10.1080/17576180.2024.2404383
Mariana Smidt, Marcos Frank Bastiani, Roberta Zilles Hahn, Lilian de Lima Feltraco Lizot, Amanda Pacheco Bondan, Giovana Piva Peteffi, Náthaly Cbf Dos Santos, José Luiz da Costa, Rafael Lanaro, Rafael Linden

Aim: Identifying drugs of abuse and their metabolites in plasma is vital in both forensic and clinical toxicology. While the QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) method offers an efficient approach to sample preparation, its application is complex due to the wide-ranging properties of target analytes and the challenges posed by biological matrix interferences. This study aims to develop a microQuEChERS approach for the quantification of 14 drugs of abuse and metabolites utilizing minimal sample and solvent volumes.Methods: The microQuEChERS method involved using 10 μl plasma samples, 25 mg of a salt mixture and 150 μl of acetonitrile. Extracts were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS), with a 7.5 min run. The assay was validated according to bioanalytical guidelines.Results: The accuracy was 96.8-112.4%. The within-assay precision was within 2.0-8.9% and the between-assay precision was within 3.2-8.2%. Matrix effects were found to range from -5.7 to 13.5%. The extraction yield was higher than 74.7%.Conclusion: This study described a microQuEChERS sample preparation approach for determining drugs of abuse and metabolites using plasma microsamples and LC-MS/MS. The approach is efficient, environmentally friendly and suitable for scenarios with limited amounts of biological samples.

目的:鉴别血浆中的滥用药物及其代谢物对法医和临床毒理学都至关重要。QuEChERS(快速、简便、廉价、有效、坚固和安全)方法提供了一种高效的样品制备方法,但由于目标分析物的各种特性以及生物基质干扰带来的挑战,该方法的应用非常复杂。本研究旨在开发一种微型 QuEChERS 方法,利用最小的样品和溶剂用量对 14 种滥用药物和代谢物进行定量分析:微量 QuEChERS 方法包括使用 10 μl 血浆样品、25 毫克盐混合物和 150 μl 乙腈。提取物采用液相色谱-串联质谱法(LC-MS/MS)进行分析,运行时间为 7.5 分钟。根据生物分析指南对该检测方法进行了验证:结果:准确度为 96.8%-112.4%。测定内精密度为 2.0-8.9%,测定间精密度为 3.2-8.2%。基质效应为-5.7%至13.5%。萃取率高于 74.7%:本研究介绍了一种利用血浆微量样品和 LC-MS/MS 测定药物滥用和代谢物的 microQuEChERS 样品制备方法。该方法高效、环保,适用于生物样本量有限的情况。
{"title":"Determination of drugs of abuse and metabolites in plasma microsamples by LC-MS/MS after microQuEChERS extraction.","authors":"Mariana Smidt, Marcos Frank Bastiani, Roberta Zilles Hahn, Lilian de Lima Feltraco Lizot, Amanda Pacheco Bondan, Giovana Piva Peteffi, Náthaly Cbf Dos Santos, José Luiz da Costa, Rafael Lanaro, Rafael Linden","doi":"10.1080/17576180.2024.2404383","DOIUrl":"10.1080/17576180.2024.2404383","url":null,"abstract":"<p><p><b>Aim:</b> Identifying drugs of abuse and their metabolites in plasma is vital in both forensic and clinical toxicology. While the QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) method offers an efficient approach to sample preparation, its application is complex due to the wide-ranging properties of target analytes and the challenges posed by biological matrix interferences. This study aims to develop a microQuEChERS approach for the quantification of 14 drugs of abuse and metabolites utilizing minimal sample and solvent volumes.<b>Methods:</b> The microQuEChERS method involved using 10 μl plasma samples, 25 mg of a salt mixture and 150 μl of acetonitrile. Extracts were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS), with a 7.5 min run. The assay was validated according to bioanalytical guidelines.<b>Results:</b> The accuracy was 96.8-112.4%. The within-assay precision was within 2.0-8.9% and the between-assay precision was within 3.2-8.2%. Matrix effects were found to range from -5.7 to 13.5%. The extraction yield was higher than 74.7%.<b>Conclusion:</b> This study described a microQuEChERS sample preparation approach for determining drugs of abuse and metabolites using plasma microsamples and LC-MS/MS. The approach is efficient, environmentally friendly and suitable for scenarios with limited amounts of biological samples.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"1055-1065"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142340405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox. 从小鼠和家兔血液中分离外周血单核细胞,以量化活性核苷酸并确定治疗天花的布林昔多福韦剂量。
IF 1.9 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-01-01 Epub Date: 2024-10-30 DOI: 10.1080/17576180.2024.2418245
Robert Hart, Shane Karnik, Kathy Van Sickle, Mark Mullin, Odin Naderer, Tim Tippin, John Dunn

Aim: Brincidofovir has been approved by the US FDA for the treatment of smallpox via the "Animal Rule". The active moiety, cidofovir diphosphate (CDV-PP), was measurable in human peripheral blood mononuclear cells (PBMCs), but quantitation in animals was challenging given their limited blood volume. The aim of this study was to optimize PBMC isolation from rabbit and mouse blood to allow quantitation of CDV-PP.Materials & methods: PBMC isolation methods using various separation media were evaluated using blood from naive and brincidofovir-dosed animals. CDV-PP was quantified using liquid chromatography tandem mass spectrometry.Results & conclusion: PBMC isolation yields were increased by >fourfold compared with yields obtained using human methods, allowing cross-species exposure comparisons.

目的:美国食品和药物管理局通过 "动物规则 "批准布林昔多福韦用于治疗天花。活性分子西多福韦二磷酸酯(CDV-PP)可在人类外周血单核细胞(PBMC)中测量,但由于动物的血容量有限,在动物体内进行定量分析具有挑战性。本研究的目的是优化兔和小鼠血液中 PBMC 的分离,以便对 CDV-PP 进行定量:材料与方法: 使用天真动物和布林昔多福韦剂量动物的血液,对使用各种分离介质的 PBMC 分离方法进行了评估。采用液相色谱串联质谱法对 CDV-PP 进行定量:结果与结论:与人类方法相比,PBMC 分离率提高了四倍以上,因此可以进行跨物种暴露比较。
{"title":"Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox.","authors":"Robert Hart, Shane Karnik, Kathy Van Sickle, Mark Mullin, Odin Naderer, Tim Tippin, John Dunn","doi":"10.1080/17576180.2024.2418245","DOIUrl":"10.1080/17576180.2024.2418245","url":null,"abstract":"<p><p><b>Aim:</b> Brincidofovir has been approved by the US FDA for the treatment of smallpox via the \"Animal Rule\". The active moiety, cidofovir diphosphate (CDV-PP), was measurable in human peripheral blood mononuclear cells (PBMCs), but quantitation in animals was challenging given their limited blood volume. The aim of this study was to optimize PBMC isolation from rabbit and mouse blood to allow quantitation of CDV-PP.<b>Materials & methods:</b> PBMC isolation methods using various separation media were evaluated using blood from naive and brincidofovir-dosed animals. CDV-PP was quantified using liquid chromatography tandem mass spectrometry.<b>Results & conclusion:</b> PBMC isolation yields were increased by >fourfold compared with yields obtained using human methods, allowing cross-species exposure comparisons.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"1179-1187"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11583588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children. 体积微样品中六种抗生素的生物分析:一种用于危重儿童精确给药的新工具。
IF 1.9 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-01-01 Epub Date: 2023-11-22 DOI: 10.4155/bio-2023-0171
John Takyi-Williams, Abbie D Leino, Ruiting Li, Kevin J Downes, Athena F Zuppa, Amanda Bwint, Bo Wen, Duxin Sun, Marc H Scheetz, Manjunath P Pai

Background: Volumetric absorptive microsamples (VAMS) can support pharmacokinetic / pharmacodynamic studies. We present the bioanalytical method development for the simultaneous quantification of ampicillin, cefepime, ceftriaxone, meropenem, piperacillin, tazobactam, and vancomycin from VAMS. Methods & results: Optimal extraction, chromatographic, and mass spectrometry conditions were identified. Maximum extraction recoveries included 100 μl of water for rehydration and methanol for protein precipitation. Chromatographic separation used Phenomenex Kinetex Polar C18 column with a mobile phase comprising water/acetonitrile with formic acid and was fully validated. Hematocrit effects were only observed for vancomycin. Samples were stable for 90 days at -80°C except for meropenem, which was stable for 60 days. Conclusion: Multiple antibiotics can be assayed from a single VAMS sample to facilitate pharmacokinetic/pharmacodynamic studies.

背景:体积吸收微样品(VAMS)可以支持药代动力学/药效学研究。我们介绍了同时定量氨苄西林、头孢吡肟、头孢曲松、美罗培南、哌拉西林、他唑巴坦和万古霉素的生物分析方法的发展。方法与结果:确定了最佳提取、色谱和质谱条件。最大提取回收率为复水合用水100 μl,蛋白质沉淀用甲醇100 μl。色谱分离使用Phenomenex Kinetex™Polar C18色谱柱,流动相为水/乙腈和甲酸,并经过充分验证。仅万古霉素对红细胞压积有影响。样品在-80℃下稳定90天,除美罗培南稳定60天外。结论:单一VAMS样品可检测多种抗生素,便于药代动力学/药效学研究。
{"title":"Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children.","authors":"John Takyi-Williams, Abbie D Leino, Ruiting Li, Kevin J Downes, Athena F Zuppa, Amanda Bwint, Bo Wen, Duxin Sun, Marc H Scheetz, Manjunath P Pai","doi":"10.4155/bio-2023-0171","DOIUrl":"10.4155/bio-2023-0171","url":null,"abstract":"<p><p><b>Background:</b> Volumetric absorptive microsamples (VAMS) can support pharmacokinetic / pharmacodynamic studies. We present the bioanalytical method development for the simultaneous quantification of ampicillin, cefepime, ceftriaxone, meropenem, piperacillin, tazobactam, and vancomycin from VAMS. <b>Methods & results:</b> Optimal extraction, chromatographic, and mass spectrometry conditions were identified. Maximum extraction recoveries included 100 μl of water for rehydration and methanol for protein precipitation. Chromatographic separation used Phenomenex Kinetex<sup>™</sup> Polar C18 column with a mobile phase comprising water/acetonitrile with formic acid and was fully validated. Hematocrit effects were only observed for vancomycin. Samples were stable for 90 days at -80°C except for meropenem, which was stable for 60 days. <b>Conclusion:</b> Multiple antibiotics can be assayed from a single VAMS sample to facilitate pharmacokinetic/pharmacodynamic studies.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"19-31"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10718164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138290193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma. 用 LC-MS/MS 方法测定人体血浆中的溴化酶抑制剂 ZEN-3694 及其代谢物 ZEN-3791。
IF 1.9 4区 医学 Q3 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-01-01 Epub Date: 2024-03-18 DOI: 10.4155/bio-2023-0252
Ye Feng, Haider Mahdi, Richard Piekarz, Jan H Beumer, Timothy W Synold

We have developed and validated a novel LC-MS/MS method for the simultaneous quantification of ZEN-3694 and its active metabolite ZEN-3791 in human plasma after protein precipitation. Stable isotope-labeled versions were used as internal standards. Chromatographic separation was achieved on a Kinetex C18 column using 0.1% formic acid in H2O and 0.1% formic acid in MeOH as mobile phases. Detection was performed via positive electrospray ionization mode with multiple reaction monitoring. The assay exhibited linearity in the concentration range of 5-5000 ng/ml for both analytes. Intra- and inter-assay precision and accuracy were within ±11%. ZEN-3694 and ZEN-3791 recoveries were between 93 and 105%. This LC-MS/MS assay is an essential tool to study ZEN-3694 in an ongoing clinical trial (NCT04840589).

我们开发并验证了一种新型的 LC-MS/MS 方法,用于同时定量蛋白质沉淀后人体血浆中的 ZEN-3694 及其活性代谢物 ZEN-3791。采用稳定同位素标记作为内标。色谱分离采用 Kinetex C18 色谱柱,以 0.1% 甲酸溶于 H2O 和 0.1% 甲酸溶于 MeOH 作为流动相。检测采用电喷雾正离子模式和多反应监测模式。两种分析物在 5-5000 纳克/毫升的浓度范围内呈线性关系。测定内和测定间的精密度和准确度均在±11%以内。ZEN-3694 和 ZEN-3791 的回收率在 93% 和 105% 之间。该 LC-MS/MS 分析法是正在进行的临床试验(NCT04840589)中研究 ZEN-3694 的重要工具。
{"title":"An LC-MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma.","authors":"Ye Feng, Haider Mahdi, Richard Piekarz, Jan H Beumer, Timothy W Synold","doi":"10.4155/bio-2023-0252","DOIUrl":"10.4155/bio-2023-0252","url":null,"abstract":"<p><p>We have developed and validated a novel LC-MS/MS method for the simultaneous quantification of ZEN-3694 and its active metabolite ZEN-3791 in human plasma after protein precipitation. Stable isotope-labeled versions were used as internal standards. Chromatographic separation was achieved on a Kinetex C18 column using 0.1% formic acid in H<sub>2</sub>O and 0.1% formic acid in MeOH as mobile phases. Detection was performed via positive electrospray ionization mode with multiple reaction monitoring. The assay exhibited linearity in the concentration range of 5-5000 ng/ml for both analytes. Intra- and inter-assay precision and accuracy were within ±11%. ZEN-3694 and ZEN-3791 recoveries were between 93 and 105%. This LC-MS/MS assay is an essential tool to study ZEN-3694 in an ongoing clinical trial (NCT04840589).</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"227-238"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11216518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140142666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bioanalysis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1